News headlines about Corindus Vascular Robotics (NYSE:CVRS) have been trending positive on Saturday, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Corindus Vascular Robotics earned a media sentiment score of 0.28 on Accern’s scale. Accern also gave news articles about the company an impact score of 46.8098980330524 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Corindus Vascular Robotics (NYSE:CVRS) traded up 0.68% on Friday, reaching $1.48. 902,994 shares of the company’s stock were exchanged. The firm’s market cap is $277.20 million. Corindus Vascular Robotics has a 12 month low of $0.40 and a 12 month high of $2.25. The firm’s 50-day moving average is $1.72 and its 200-day moving average is $1.30.
COPYRIGHT VIOLATION WARNING: “Positive Press Coverage Somewhat Unlikely to Affect Corindus Vascular Robotics (CVRS) Share Price” was originally posted by Rincon Hill News and is the property of of Rincon Hill News. If you are reading this article on another domain, it was illegally copied and republished in violation of United States and international copyright law. The legal version of this article can be accessed at https://rinconhillneighbors.org/2017/08/19/corindus-vascular-robotics-cvrs-receives-media-impact-score-of-0-28-updated.html.
About Corindus Vascular Robotics
Corindus Vascular Robotics, Inc is engaged in robotic-assisted vascular interventions. The Company’s CorPath System is a medical device that brings robotic-assisted precision to radial, coronary and peripheral procedures. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries.
Receive News & Ratings for Corindus Vascular Robotics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics Inc and related companies with our FREE daily email newsletter.